Press Release Archives - Page 24 of 24

Spectral Medical Inc. Announces Proposed Public Offering of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario | March 5, 2019 TORONTO, March 05, 2020 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...

Baxter and Spectral Medical Announce Exclusive Distribution Agreement For Blood Filter in U.S. and Canada

Agreement will enable Baxter to expand its Acute Therapies portfolio to address unmet needs Agreement provides Spectral with a strategic commercialization partner and their access to a large number of hospitals Spectral to receive upfront exclusive rights payment ...

Next Entries »

EAA™ and PMX are licensed and available for use in Canada. PMX is not approved for clinical use in the USA, and is currently undergoing the PMA (Premarket approval) process. EAA™ is FDA cleared for use in the USA. The information presented herein is region specific. Please contact Spectral Medical Inc.to obtain appropriate product information for your country.

Spectral Medical Inc. Announces Proposed Public Offering of Common Shares

Baxter and Spectral Medical Announce Exclusive Distribution Agreement For Blood Filter in U.S. and Canada

Recent Releases